Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk

AIDS Research and Human Retroviruses

Volumn 24, Issue 2, 2008, Pages 117-123

  Cherry, Catherine L ^a,b,c   Rosenow, Ann ^d   Affandi, Jacquita S ^e   McArthur, Justin C ^f   Wesselingh, Steven L ^a,b,c   Price, Patricia ^d  

^a BURNET INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e MURDOCH UNIVERSITY   (Australia)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; HLA A1 ANTIGEN; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; INTERLEUKIN 12P40; PROTEIN BAT1; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROGENIC INFLAMMATION; PRIORITY JOURNAL; RISK FACTOR; SENSORY NEUROPATHY;

ADULT; ANTI-HIV AGENTS; AUSTRALIA; BODY HEIGHT; CYTOKINES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIV INFECTIONS; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; NEURITIS; POLYMORPHISM, GENETIC; SOMATOSENSORY DISORDERS;

EID: 39549113449     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0168     Document Type: Article

References (40)

1. Palella F, Delaney K, Moorman A, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Keswani S, Pardo C, Cherry C, Hoke A, and McArthur J: HIV-associated sensory neuropathies. AIDS 2002;16(16):2105-2117.
3. Cherry C, Skolasky R, Lal L, et al.: Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology 2006;66:867-873.
4. Lichtenstein K, Armon C, Baron A, et al.: Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 2005;40(1):148-157.
5. Price P, Morahan G, Huang D, et al.: Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002;16(15):2043-2047.
6. Quasney M, Zhang Q, Sargent S, Mynatt M, Glass J, and McArthur J: Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia. Ann Neurol 2001;50(2):157-162.
7. Nagano I, Shapshak P, Yoshioka M, Xin K, Nakamura S, and Bradley W: Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome. J Neurol Sci 1996;136(1-2):117- 128.
8. Wesselingh S, Glass J, McArthur J, Griffin J, and Griffin D: Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol 1994;4:199-206.
9. Tyor W, Wesselingh S, Griffin J, McArthur J, and Griffin D: Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:379-388.
10. Maher B, Alfirevic A, Vilar FJ, Wilkins EG, Park BK, and Pirmohamed M: TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy. AIDS 2002;16:2013-2018.
11. Mallal S, Nolan D, Witt C, et al.: Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002;359(9308):727-732.
12. Kallianpur A, Hulgan T, Canter J, et al.: Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS 2006;20(11):1503-1513.
13. Temple S, Cheong K, Ardlie K, Sayer D, and Waterer G: The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B. Intensive Care Med 2004;30:1761-1767.
14. Price P, Witt C, Allcock R, et al.: The genetic basis for the association of the 8.1 ancestral haplotype with multiple immunopathological diseases. Immunol Rev 1999;167:257-274.
15. Allcock R, Windsor L, Gut I, et al.: High-density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: Implications for haplotype testing. Hum Mutat 2004;24:517-525.
16. Cheng Y, Gregg E, Kahn H, Williams D, De Rekeneire N, and Narayan K: Peripheral insensate neuropathy - a tall problem for US adults? Am J Epidemiol 2006;164(9):873-880.
17. Cherry C, Wesselingh S, Lal L, and McArthur J: Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology 2005;65:1778-1781.
18. Price P, James I, Fernandez S, and French M: Alleles of the gene encoding IL-1A may predict control of plasma viraemia in HIV-1 patients on highly active antiretroviral therapy. AIDS 2004;18:1495-1501.
19. Windsor L, Morahan G, Huang D, et al.: Alleles of the IL12B 3′UTR associate with late onset of type 1 diabetes. Hum Immunol 2004;65(12):1432-1436.
20. Wilson A, Clay F, Crane A, Cork M, and Duff G: Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis. J Invest Dermatol 1995;104:856-858.
21. Fernandez S, Rosenow A, James I, et al.: Recovery of CD4-+ T cells in HIV patients with a stable virologic response to antiretroviral therapy is associated with polymorphisms of interleukin-6 and central major histocompatibility complex genes. J Acquir Immune Defic Syndr 2006;41(1):1-5.
22. Temple S, Lim E, Cheong K, et al.: Alleles carried at positions - 819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003;55:629-632.
23. Hofer H, Neufeld J, Oesterreicher C, et al.: Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun 2005;6(3):242-247.
24. Brew BJ, Tisch S, and Law M: Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy (research letter). AIDS 2003;17(7):1094-1096.
25. Pettersen J, Jones G, Worthington C, et al.: Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: Protease inhibitor-mediated neurotoxicity. Ann Neurol 2006;59:816-824.
26. Smyth K, Affandi J, McArthur J, et al.: Prevalence and changing risk factors for HIV-associated neuropathy in Melbourne, Australia. HIV Med 2007;8(6):367-373.
27. Estanislao L, Morgello S, and Simpson D: Peripheral neuropathies associated with HIV and hepatitis C co-infection: A review. AIDS 2005;19(Suppl. 3):S135-S139.
28. Park K, Kim N, Nam J, Bang D, and Lee E: Association of TNFA promoter region haplotype in Behcet's disease. J Korean Med Sci 2006;21(4):596-601.
29. Ahn J, Yu H, Chung H, and Park Y: Intraocular cytokine environment in active Behcet uveitis. Am J Ophthalmol 2006;142(3):429-434.
30. Delgado J, Leung J, Baena A, et al.: The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia. Immunogenetics 2003;55(7):497-501.
31. Maher B, Alfirevic A, Vilar F, Wilkins E, Park B, and Pirmohamed M: TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy. AIDS 2002;16(15):2013-2018.
32. Price P, Calder D, Witt C, et al.: Periodontal attachment loss in HIV-infected patients is associated with the major histocompatibility complex 8.1 haplotype (HLA-A1,B8,DR3). Tissue Antigens 1999;54:391-399.
33. Louis E, Franchimont D, Piron A, et al.: Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113(3):401-406.
34. Abraham L and Kroeger K: Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease. J Leukoc Biol 1999;66(4):562-566.
35. Price P, Bolitho P, Jaye A, et al.: A Gambian TNF haplotype matches the European HLA-A1,B8,DR3 and Chinese HLAA33, B58,DR3 haplotypes. Tissue Antigens 2003;62(1):72-75.
36. Yilmaz V, Yentur S, and Saruhan-Direskeneli G: IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005;30:188-194.
37. Nakayama E, Meyer L, Iwamoto A, et al.: Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: Relationship with virus load. J Infect Dis 2002;185(8):1183-1186.
38. Shin H, Winkler C, Stephens J, et al.: Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA 2000;97(26):14467-14472.
39. Lindegaard B, Hansen A, Pilegaard H, Keller P, Gerstoft J, and Pedersen B: Adipose tissue expression of IL-18 and HIV-associated lipodystrophy. AIDS 2004;18(14):1956-1958.
40. Tapp R, Shaw J, de Courten M, et al.: Foot complications in Type 2 diabetes: An Australian population-based study. Diabetes Med 2003;20(2):105-113.